biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Down on somewhat heavy volume

<< Previous

Bullboard Posts

Next >>

Comment by craighenryon Feb 19, 2021 9:12pm

115 Views

Post# 32617068

RE:RE:RE:Down on somewhat heavy volume

beenthere wrote: JD, is that you? lol

craighenry the " JD parrot " lol

Have you memorized JD's posts over the years craighenry?

You sure do sound like him and just as " useless " I might add! lol

Go to bed you old senile pathetic man. You also olay the victim card and try to blame JD or Kayaker because BTI share price hasn't performed to your liking or what THEY think it will be at. You blame others for your investment decision old man. You are pathetic. Simple!!

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?